Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2024

Open Access 01-12-2024 | Dementia | Research

Panax notoginseng saponins prevent dementia and oxidative stress in brains of SAMP8 mice by enhancing mitophagy

Authors: Yingying Yang, Wenya Chen, Zhenmei Lin, Yijing Wu, Yuqing Li, Xing Xia

Published in: BMC Complementary Medicine and Therapies | Issue 1/2024

Login to get access

Abstract

Background

Mitochondrial dysfunction is one of the distinctive features of neurons in patients with Alzheimer’s disease (AD). Intraneuronal autophagosomes selectively phagocytose and degrade the damaged mitochondria, mitigating neuronal damage in AD. Panax notoginseng saponins (PNS) can effectively reduce oxidative stress and mitochondrial damage in the brain of animals with AD, but their exact mechanism of action is unknown.

Methods

Senescence-accelerated mouse prone 8 (SAMP8) mice with age-related AD were treated with PNS for 8 weeks. The effects of PNS on learning and memory abilities, cerebral oxidative stress status, and hippocampus ultrastructure of mice were observed. Moreover, changes of the PTEN-induced putative kinase 1 (PINK1)-Parkin, which regulates ubiquitin-dependent mitophagy, and the recruit of downstream autophagy receptors were investigated.

Results

PNS attenuated cognitive dysfunction in SAMP8 mice in the Morris water maze test. PNS also enhanced glutathione peroxidase and superoxide dismutase activities, and increased glutathione levels by 25.92% and 45.55% while inhibiting 8-hydroxydeoxyguanosine by 27.74% and the malondialdehyde production by 34.02% in the brains of SAMP8 mice. Our observation revealed the promotion of mitophagy, which was accompanied by an increase in microtubule-associated protein 1 light chain 3 (LC3) mRNA and 70.00% increase of LC3-II/I protein ratio in the brain tissues of PNS-treated mice. PNS treatment increased Parkin mRNA and protein expression by 62.80% and 43.80%, while increasing the mRNA transcription and protein expression of mitophagic receptors such as optineurin, and nuclear dot protein 52.

Conclusion

PNS enhanced the PINK1/Parkin pathway and facilitated mitophagy in the hippocampus, thereby preventing cerebral oxidative stress in SAMP8 mice. This may be a mechanism contributing to the cognition-improvement effect of PNS.
Appendix
Available only for authorised users
Literature
1.
2022 Alzheimer’s disease facts and figures. Alzheimers Dement. 2022;18:700 – 89.
2.
Dubois B, Villain N, Frisoni GB, Rabinovici GD, Sabbagh M, Cappa S, et al. Clinical diagnosis of Alzheimer’s disease: recommendations of the international working group. Lancet Neurol. 2021;20:484–96.CrossRefPubMedPubMedCentral
3.
Yu TW, Lane HY, Lin CH. Novel therapeutic approaches for Alzheimer’s disease: an updated review. Int J Med Sci. 2021;22:8208.
4.
Blanco-Silvente L, Capellà D, Garre-Olmo J, Vilalta-Franch J, Castells X. Predictors of discontinuation, efficacy, and safety of memantine treatment for Alzheimer’s disease: meta-analysis and meta-regression of 18 randomized clinical trials involving 5004 patients. BMC Geriatr. 2018;18:168.CrossRefPubMedPubMedCentral
5.
Blanco-Silvente L, Castells X, Saez M, Barceló MA, Garre-Olmo J, Vilalta-Franch J, et al. Discontinuation, efficacy, and safety of cholinesterase inhibitors for Alzheimer’s disease: a meta-analysis and meta-regression of 43 randomized clinical trials enrolling 16 106 patients. Int J Neuropsychoph. 2017;20:519–28.CrossRef
6.
Li P, Feng D, Yang D, Li X, Sun J, Wang G, et al. Protective effects of anthocyanins on neurodegenerative diseases. Trends Food Sci Tec. 2021;117:205–17.CrossRef
7.
Ionescu-Tucker A, Cotman CW. Emerging roles of oxidative stress in brain aging and Alzheimer’s disease. Neurobiol Aging. 2021;107:86–95.CrossRefPubMed
8.
Zhang Z, Yang X, Song Y-Q, Tu J. Autophagy in Alzheimer’s disease pathogenesis: therapeutic potential and future perspectives. Ageing Res Rev. 2021;72:101464.CrossRefPubMed
9.
Sharma C, Kim S, Nam Y, Jung UJ, Kim SR. Mitochondrial dysfunction as a driver of cognitive impairment in Alzheimer’s disease. Int J Mol Sci. 2021;22:4850.CrossRefPubMedPubMedCentral
10.
Wang W, Zhao F, Ma X, Perry G, Zhu X. Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances. Mol Neurodegener. 2020;15:30.CrossRefPubMedPubMedCentral
11.
Liu H, Huang H, Li R, Bi W, Feng L. Mitophagy protects SH-SY5Y neuroblastoma cells against the TNFα-induced inflammatory injury: involvement of microRNA-145 and Bnip3. Biomed Pharmacother. 2019;109:957–68.CrossRefPubMed
12.
Lou G, Palikaras K, Lautrup S, Scheibye-Knudsen M, Tavernarakis N, Fang EF. Mitophagy and neuroprotection. Trends Mol Med. 2020;26:8–20.CrossRefPubMed
13.
Chao H, Lin C, Zuo Q, Liu Y, Xiao M, Xu X, et al. Cardiolipin-dependent mitophagy guides outcome after traumatic brain injury. J Neurosci. 2019;39:1930–43.CrossRefPubMedPubMedCentral
14.
15.
Harper JW, Ordureau A, Heo J-M. Building and decoding ubiquitin chains for mitophagy. Nat Rev Mol Cell Biol. 2018;19:93–108.CrossRefPubMed
16.
Nguyen TN, Padman BS, Lazarou M. Deciphering the molecular signals of PINK1/Parkin mitophagy. Trends Cell Biol. 2016;26:733–44.CrossRefPubMed
17.
Wu X, Li X, Liu Y, Yuan N, Li C, Kang Z, et al. Hydrogen exerts neuroprotective effects on OGD/R damaged neurons in rat hippocampal by protecting mitochondrial function via regulating mitophagy mediated by PINK1/Parkin signaling pathway. Brain Res. 2018;1698:89–98.CrossRefPubMed
18.
Sun T, Wang P, Deng T, Tao X, Li B, Xu Y. Effect of Panax notoginseng saponins on focal cerebral ischemia-reperfusion in rat models: a meta-analysis. Front Pharmacol. 2020;11:572304.CrossRefPubMed
19.
Liu B, Li Y, Han Y, Wang S, Yang H, Zhao Y, et al. Notoginsenoside R1 intervenes degradation and redistribution of tight junctions to ameliorate blood-brain barrier permeability by Caveolin-1/MMP2/9 pathway after acute ischemic stroke. Phytomedicine. 2021;90:153660.CrossRefPubMed
20.
Zeng XS, Zhou XS, Luo FC, Jia JJ, Qi L, Yang ZX, et al. Comparative analysis of the neuroprotective effects of ginsenosides Rg1 and Rb1 extracted from Panax notoginseng against cerebral ischemia. Can J Physiol Pharmacol. 2014;92:102–8.CrossRefPubMed
21.
Xu D, Huang P, Yu Z, Xing DH, Ouyang S, Xing G. Efficacy and safety of Panax notoginseng saponin therapy for acute intracerebral hemorrhage, meta-analysis, and mini review of potential mechanisms of action. Front Neurol. 2014;5:274.PubMed
22.
Dai L, Zhang Y, Jiang Y, Chen K. Panax notoginseng preparation plus aspirin versus aspirin alone on platelet aggregation and coagulation in patients with coronary heart disease or ischemic stroke: a meta-analysis of randomized controlled trials. Front Pharmacol. 2022;13:1015048.CrossRefPubMedPubMedCentral
23.
Wang LD, Xu ZM, Liang X, Qiu WR, Liu SJ, Dai LL, et al. Systematic review and meta-analysis on randomized controlled trials on efficacy and safety of Panax notoginseng saponins in treatment of acute ischemic stroke. Evid Based Complement Alternat Med. 2021;2021:4694076.PubMedPubMedCentral
24.
Chen XJ, Qiu JF, Wang YT, Wan JB. Discrimination of three Panax species based on differences in volatile organic compounds using a static headspace GC-MS-based metabolomics approach. Am J Chin Med. 2016;44:663–76.CrossRefPubMed
25.
Huang J, Wu D, Wang J, Li F, Lu L, Gao Y, et al. Effects of Panax notoginseng saponin on α, β, and γ secretase involved in Aβ deposition in SAMP8 mice. NeuroReport. 2014;25:89–93.CrossRefPubMed
26.
Huang Y, Guo B, Shi B, Gao Q, Zhou Q. Chinese herbal medicine xueshuantong enhances cerebral blood flow and improves neural functions in Alzheimer’s disease mice. J Alzheimers Dis. 2018;63:1089–107.CrossRefPubMedPubMedCentral
27.
Zhou L, Huang PP, Chen LL, Wang P. Panax notoginseng saponins ameliorate Aβ-mediated neurotoxicity in C. Elegans through antioxidant activities. Evid Based Complement Alternat Med. 2019;2019:7621043.CrossRefPubMedPubMedCentral
28.
29.
Huang JL, Xu ZH, Yang SM, Yu C, Zhang F, Qin MC, et al. Identification of differentially expressed profiles of Alzheimer’s disease associated circular RNAs in a Panax notoginseng saponins-treated Alzheimer’s disease mouse model. Comput Struct Biotechnol J. 2018;16:523–31.CrossRefPubMedPubMedCentral
30.
Nomura Y, Wang BX, Qi SB, Namba T, Kaneko S. Biochemical changes related to aging in the senescence-accelerated mouse. Exp Gerontol. 1989;24:49–55.CrossRefPubMed
31.
Liu B, Liu J, Shi JS. SAMP8 mice as a model of age-related cognition decline with underlying mechanisms in Alzheimer’s disease. JAD. 2020;75:385–95.CrossRefPubMed
32.
Vasilopoulou F, Bellver-Sanchis A, Companys-Alemany J, Jarne-Ferrer J, Irisarri A, Palomera-Ávalos V, et al. Cognitive decline and BPSD are concomitant with autophagic and synaptic deficits associated with g9a alterations in aged SAMP8 mice. Cells. 2022;11:2603.CrossRefPubMedPubMedCentral
33.
Huang JL, Jing X, Tian X, Qin MC, Xu ZH, Wu DP, et al. Neuroprotective properties of Panax notoginseng saponins via preventing oxidative stress injury in SAMP8 mice. Evid Based Complement Alternat Med. 2017;2017:8713561.CrossRefPubMedPubMedCentral
34.
Yang ZP, Bao YM. Research progress on regulation effect of Panax notoginseng saponins on mitochondria. Zhongguo Zhong Yao Za Zhi. 2017;42:870–4.PubMed
35.
Liu XW, Lu MK, Zhong HT, Wang LH, Fu YP. Panax notoginseng saponins attenuate myocardial ischemia-reperfusion injury through the HIF-1α/BNIP3 pathway of autophagy. J Cardiovasc Pharmacol. 2019;73:92–9.CrossRefPubMed
36.
Liang X, Yang Y, Huang Z, Zhou J, Li Y, Zhong X. Panax notoginseng saponins mitigate cisplatin induced nephrotoxicity by inducing mitophagy via HIF-1α. Oncotarget. 2017;8:102989–3003.CrossRefPubMedPubMedCentral
37.
Xiao Q, Kang Z, Liu C, Tang B. Panax notoginseng saponins attenuate cerebral ischemia-reperfusion injury via mitophagy-induced inhibition of NLRP3 inflammasome in rats. Front Biosci (Landmark Ed). 2022;27:300.CrossRefPubMed
38.
Zhou P, Xie W, Meng X, Zhai Y, Dong X, Zhang X, et al. Notoginsenoside R1 ameliorates diabetic retinopathy through PINK1-dependent activation of mitophagy. Cells. 2019;8:213.CrossRefPubMedPubMedCentral
39.
Jiang Y, Li H, Huang P, Li S, Li B, Huo L, et al. Panax notoginseng saponins protect PC12 cells against Aβ induced injury via promoting parkin-mediated mitophagy. J Ethnopharmacol. 2022;285:114859.CrossRefPubMed
40.
Chiba Y, Shimada A, Kumagai N, Yoshikawa K, Ishii S, Furukawa A, et al. The senescence-accelerated mouse (SAM): a higher oxidative stress and age-dependent degenerative diseases model. Neurochem Res. 2009;34:679–87.CrossRefPubMed
41.
Huang H-J, Chen J-L, Liao J-F, Chen Y-H, Chieu M-W, Ke Y-Y, et al. Lactobacillus plantarum PS128 prevents cognitive dysfunction in Alzheimer’s disease mice by modulating propionic acid levels, glycogen synthase kinase 3 beta activity, and gliosis. BMC Complement Med Ther. 2021;21:259.CrossRefPubMedPubMedCentral
42.
Rajabian A, Rameshrad M, Hosseinzadeh H. Therapeutic potential of Panax ginseng and its constituents, ginsenosides and gintonin, in neurological and neurodegenerative disorders: a patent review. Expert Opin Ther Pat. 2019;29:55–72.CrossRefPubMed
43.
44.
Kang S, Shin KD, Kim JH, Chung T. Autophagy-related (ATG) 11, ATG9 and the phosphatidylinositol 3-kinase control ATG2-mediated formation of autophagosomes in Arabidopsis. Plant Cell Rep. 2018;37:653–64.CrossRefPubMed
45.
46.
Liu WJ, Gan Y, Huang WF, Wu HL, Zhang XQ, Zheng HJ, et al. Lysosome restoration to activate podocyte autophagy: a new therapeutic strategy for diabetic kidney disease. Cell Death Dis. 2019;10:806.CrossRefPubMedPubMedCentral
47.
48.
49.
50.
Panigrahi DP, Praharaj PP, Bhol CS, Mahapatra KK, Patra S, Behera BP, et al. The emerging, multifaceted role of mitophagy in cancer and cancer therapeutics. Semin Cancer Biol. 2020;66:45–58.CrossRefPubMed
51.
Ma H, Guo Z, Gai C, Cheng C, Zhang J, Zhang Y, et al. Protective effects of Buyinqianzheng formula on mitochondrial morphology by PINK1/Parkin pathway in SH-SY5Y cells induced by MPP+. J Tradit Chin Med Sci. 2020;7:274–82.
52.
53.
Quinn PMJ, Moreira PI, Ambrósio AF, Alves CH. PINK1/PARKIN signalling in neurodegeneration and neuroinflammation. Acta Neuropathol Com. 2020;8:189.CrossRef
54.
Olagunju AS, Ahammad F, Alagbe AA, Otenaike TA, Teibo JO, Mohammad F, et al. Mitochondrial dysfunction: a notable contributor to the progression of Alzheimer’s and Parkinson’s disease. Heliyon. 2023;9:e14387.CrossRefPubMedPubMedCentral
55.
Li J, Yang D, Li Z, Zhao M, Wang D, Sun Z, et al. PINK1/Parkin-mediated mitophagy in neurodegenerative diseases. Ageing Res Rev. 2023;84:101817.CrossRefPubMed
56.
57.
Palikaras K, Lionaki E, Tavernarakis N. Mechanisms of mitophagy in cellular homeostasis, physiology and pathology. Nat Cell Biol. 2018;20:1013–22.CrossRefPubMed
58.
Padman BS, Nguyen TN, Uoselis L, Skulsuppaisarn M, Nguyen LK, Lazarou M. LC3/GABARAPs drive ubiquitin-independent recruitment of optineurin and NDP52 to amplify mitophagy. Nat Commun. 2019;10:408.CrossRefPubMedPubMedCentral
59.
Lazarou M, Sliter DA, Kane LA, Sarraf SA, Wang C, Burman JL, et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature. 2015;524:309–14.CrossRefPubMedPubMedCentral
Metadata
Title
Panax notoginseng saponins prevent dementia and oxidative stress in brains of SAMP8 mice by enhancing mitophagy
Authors
Yingying Yang
Wenya Chen
Zhenmei Lin
Yijing Wu
Yuqing Li
Xing Xia
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2024
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-024-04403-7

Other articles of this Issue 1/2024

BMC Complementary Medicine and Therapies 1/2024 Go to the issue

Research

Comparison of the protective effects of CS/TPP and CS/HPMCP nanoparticles containing berberine in ethanol-induced hepatotoxicity in rat

Research

The effects of grape seed extract supplementation on cardiovascular risk factors, liver enzymes and hepatic steatosis in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study

Research

Punicalagin, a pomegranate polyphenol sensitizes the activity of antibiotics against three MDR pathogens of the Enterobacteriaceae

Research

Ethnomedicine, antibacterial activity, antioxidant potential and phytochemical screening of selected medicinal plants in Dibatie district, Metekel zone, western Ethiopia

Research

Effects of Spirulina supplementation in patients with ulcerative colitis: a double-blind, placebo-controlled randomized trial

Research

Crataegus pentagyna willd. Fruits, leaves and roots: phytochemicals, antioxidant and antimicrobial potentials